EyeCool Therapeutics Welcomes Dr. Vance Thompson to Its Board of Directors EyeCool Therapeutics appoints Dr. Vance Thompson to its board, enhancing its expertise in tackling chronic ocular pain with innovative technology.

EyeCool Therapeutics Welcomes Dr. Vance Thompson to Its Board of Directors #USA #Cambridge #EyeCool_Therapeutics #Vance_Thompson #ocular_pain

EyeCool Therapeutics Reports Positive Results from Clinical Trial on Chronic Ocular Surface Pain Treatment EyeCool Therapeutics has announced positive outcomes from a pivotal clinical trial assessing its device aimed at treating chronic ocular surface pain, marking a significant innovation in eye care.

EyeCool Therapeutics Reports Positive Results from Clinical Trial on Chronic Ocular Surface Pain Treatment #United_States #Cambridge #EyeCool_Therapeutics #COSP #ETX-4143